clavulanic acid has been researched along with Community Acquired Infection in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bach Le, HT; Bach Nguyen, YT; Minh Nguyen, C; Ngoc Bui, HT; Ngoc Phan, TT; Nguyen, T; Thanh Tran, T; Thanh Vo, TT; Thu Le, TT; Thu Nguyen, HT; Tran, HD; Tran, HG; Tuong Mai, V; Yong, N | 1 |
| Adeleke, G; Egbagbe, E; Ejembi, J; Ettu, AO; Habib, A; Irowa, OO; Makanjuola, OB; Medugu, N; Mutiu, B; Ogunbosi, B; Ogunsola, F; Oladele, RO; Osinaike, T; Rotimi, V; Uwaezuoke, NS | 1 |
| Becker, P; Greeff, O; Xaba, SN | 1 |
| Harasawa, K; Kagiyama, N; Kurashima, K; Matusita, F; Miyahara, Y; Saito, H; Sugita, Y; Takayanagi, N; Tokunaga, D; Ubukata, M; Yamaguchi, S; Yanagisawa, T; Yano, R; Yoneda, K | 1 |
| Aggarwal, P; Capoor, MR; Deb, M; Hasan, AS; Nair, D; Pillai, P; Rawat, D; Sarma, S | 1 |
| Galani, I; Giamarellou, H; Katsarolis, I; Lampri, N; Petrikkos, G; Poulakou, G; Souli, M | 1 |
| Díaz de Tuesta Chow-Quan, AM; Dimas Nuñez, JF; Geijo Martínez, MP; Gómez Criado, C; Herranz, CR; Saiz García, F | 1 |
| Bertrand, X; Lallemand-De-Conto, S; Talon, D; Thouverez, M | 1 |
| Feldman, C; File, T; Léophonte, P | 1 |
| Lee, WK; Young, BW | 1 |
| Bonten, MJ; Buskens, E; Hoepelman, AI; Hustinx, WM; Kaasjager, K; Kramer, MH; Lammers, JW; Oosterheert, JJ; Prins, JM; Schneider, MM; Slee, PH | 1 |
| Brousse, C; Chanez, P; Darbas, H; Godard, P; Jonquet, O; Lilienthal, F; Michel, FB; Paganin, F | 1 |
| Lee, SK; Ng, AW; Oh, HM | 1 |
| Léophonte, P; Veyssier, P | 1 |
| Amores, R; Calvo, A; Prieto, J; Sevillano, D; Valero, E | 1 |
5 trial(s) available for clavulanic acid and Community Acquired Infection
| Article | Year |
|---|---|
[Levofloxacin versus beta-lactamic therapy in community acquired pneumonia that requires hospitalization].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Clavulanic Acid; Community-Acquired Infections; Drug Therapy, Combination; Female; Hospitalization; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 2002 |
Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clavulanic Acid; Community-Acquired Infections; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Gemifloxacin; Humans; Male; Middle Aged; Naphthyridines; Pneumonia, Pneumococcal; Treatment Outcome | 2004 |
Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clavulanic Acid; Community-Acquired Infections; Drug Combinations; Humans; Infusions, Intravenous; Middle Aged; Pneumonia, Bacterial; Time Factors; Treatment Outcome | 2006 |
Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Community-Acquired Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Penicillins; Pneumonia, Bacterial; Treatment Outcome | 1996 |
[Levofloxacin in the treatment of community-acquired pneumococcal pneumonia].
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Clavulanic Acid; Community-Acquired Infections; Drug Therapy, Combination; Humans; Levofloxacin; Middle Aged; Ofloxacin; Pneumonia, Pneumococcal | 1999 |
10 other study(ies) available for clavulanic acid and Community Acquired Infection
| Article | Year |
|---|---|
Community-acquired pneumonia-causing bacteria and antibiotic resistance rate among Vietnamese patients: A cross-sectional study.
Topics: Amoxicillin; Anti-Bacterial Agents; Asian People; Bacteria; Clavulanic Acid; Community-Acquired Infections; Cross-Sectional Studies; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Pneumonia, Pneumococcal | 2022 |
Antibiotic Guidelines for Critically Ill Patients in Nigeria.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clavulanic Acid; Community-Acquired Infections; Critical Illness; Cross Infection; Fluconazole; Humans; Meropenem; Microbial Sensitivity Tests; Nigeria; Piperacillin, Tazobactam Drug Combination; Pneumonia; Prospective Studies; Urinary Tract Infections | 2023 |
Determinants, outcomes and costs of ceftriaxone v. amoxicillin-clavulanate in the treatment of community-acquired pneumonia at Witbank Hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminopyridines; Ceftriaxone; Clavulanic Acid; Community-Acquired Infections; Drug Combinations; Female; Humans; Length of Stay; Male; Middle Aged; Pneumonia; Sex Factors; Treatment Outcome | 2014 |
[Case of pneumonia caused by beta-lactamase-producing and amoxicillin/clavulanate resistant strains of H. influenzae].
Topics: Aged, 80 and over; Ampicillin; beta-Lactam Resistance; beta-Lactamases; Clavulanic Acid; Community-Acquired Infections; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Pneumonia, Bacterial | 2008 |
In vitro evaluation of a new cefixime-clavulanic acid combination for gram-negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefixime; Clavulanic Acid; Community-Acquired Infections; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests | 2009 |
Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactamases; Clavulanic Acid; Community-Acquired Infections; DNA, Bacterial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Greece; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Urinary Tract Infections | 2012 |
[E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ceftazidime; Cephalothin; Ciprofloxacin; Clavulanic Acid; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Genotype; Humans; Male; Middle Aged; Nalidixic Acid; Phenotype; Selection, Genetic; Urinary Tract Infections | 2004 |
Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Clavulanic Acid; Community-Acquired Infections; Drug Prescriptions; Erythromycin; Hong Kong; Humans; Infant; Penicillin Resistance; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Prevalence; Streptococcus pneumoniae | 2005 |
[Community acquired pneumonias in the region of Montpellier. Increase of pneumococci with reduced sensitivity to penicillins].
Topics: Adolescent; Adult; Aged; Clavulanic Acid; Clavulanic Acids; Community-Acquired Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Female; France; Haemophilus influenzae; Humans; Incidence; Male; Middle Aged; Penicillin Resistance; Penicillins; Pneumonia, Pneumococcal; Prospective Studies; Streptococcus pneumoniae | 1995 |
[Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefixime; Cefpodoxime; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acid; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Spain; Streptococcus pneumoniae | 2001 |